
SubjectWell
Risk-free patient recruitment for clinical trials.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor investor investor investor investor | €0.0 | round |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
investor | €0.0 | round | |
N/A | €0.0 | round | |
investor investor investor | €0.0 | round | |
investor | €0.0 Valuation: €0.0 | round | |
investor investor investor investor | €0.0 | round | |
* | N/A | Buyout | |
Total Funding | 000k |









USD | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% growth | - | 159 % | 192 % | 37 % | 80 % | - |
EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Dealroom estimates
Related Content
SubjectWell is a startup that specializes in patient recruitment for clinical trials. The company operates in the healthcare and pharmaceutical sectors, serving clients such as pharmaceutical companies, biotech firms, and clinical research organizations. SubjectWell's primary service is to connect these clients with qualified patients who are willing to participate in clinical trials.
The company leverages real-time data to identify and refer patients who meet the specific criteria of a given study. This data-driven approach allows SubjectWell to deliver referrals at a much faster rate compared to traditional methods. Their "high touch" approach means they actively engage with patients, which results in higher randomization rates—patients who are more likely to be selected and participate in the trial.
SubjectWell's business model is performance-based, meaning clients only pay for patients who actually randomize into the clinical trial. This reduces financial risk for their clients, as they are not paying upfront for uncertain outcomes. The company offers a risk-free assessment to potential clients, using real-world data to estimate how many qualified patients they can recruit for a specific study. This customized analysis helps clients understand how quickly they can meet their enrollment goals.
In summary, SubjectWell accelerates the patient recruitment process for clinical trials, providing a cost-effective and efficient solution for their clients. By focusing on real-time data and a performance-based payment model, they minimize financial risk and maximize the likelihood of successful patient enrollment.
Keywords: patient recruitment, clinical trials, healthcare, pharmaceutical, biotech, real-time data, high touch approach, randomization rates, performance-based, risk-free assessment.
Tech stack
Investments by SubjectWell
Edit
